Ionis Pharmaceuticals Files 8-K Report
Ticker: IONS · Form: 8-K · Filed: Apr 21, 2026 · CIK: 0000874015
| Field | Detail |
|---|---|
| Company | Ionis Pharmaceuticals Inc (IONS) |
| Form Type | 8-K |
| Filed Date | Apr 21, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, sec
Related Tickers: IONS
TL;DR
IONIS filed an 8-K, check exhibits for details.
AI Summary
On April 21, 2026, Ionis Pharmaceuticals, Inc. filed an 8-K report detailing events under Items 7.01, 8.01, and 9.01. The filing includes an exhibit (EX-99.1) and XBRL data, but no specific financial figures or material events are disclosed in the provided text.
Why It Matters
This filing indicates Ionis Pharmaceuticals is providing updates or disclosures to the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific material disclosures that would indicate immediate risk.
Key Players & Entities
- IONIS PHARMACEUTICALS INC (company) — Filer
- 0000874015 (company) — CIK
- 2855 GAZELLE COURT CARLSBAD CA 92010 (location) — Mailing and Business Address
- 2026-04-21 (date) — Filing Date
FAQ
What specific information is contained in Exhibit 99.1?
The provided text does not specify the content of Exhibit 99.1, only that it is part of the filing.
What are the key disclosures under Items 7.01, 8.01, and 9.01?
The filing lists these items as being addressed, but the specific details of the disclosures are not present in the provided text.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-21 at 07:00:40.
What is the CIK number for Ionis Pharmaceuticals, Inc.?
The CIK number for Ionis Pharmaceuticals, Inc. is 0000874015.
What is the business address of Ionis Pharmaceuticals, Inc.?
The business address is 2855 GAZELLE COURT CARLSBAD CA 92010.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2026 regarding IONIS PHARMACEUTICALS INC (IONS).